title: DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
authors.forename: G
authors.initials: G
authors.lastname: Marcacci
authors.forename: G
authors.initials: G
authors.lastname: Corazzelli
authors.forename: C
authors.initials: C
authors.lastname: Becchimanzi
authors.forename: M
authors.initials: M
authors.lastname: Arcamone
authors.forename: G
authors.initials: G
authors.lastname: Capobianco
authors.forename: F
authors.initials: F
authors.lastname: Russo
authors.forename: F
authors.initials: F
authors.lastname: Frigeri
authors.forename: A
authors.initials: A
authors.lastname: Pinto
mesh_terms: D000328:Adult; D002490:Central Nervous System / Q000378:metabolism*; D015925:Cryopreservation; D004121:Dimethyl Sulfoxide / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000628:therapy; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects*; D014182:Transplantation, Autologous
chemical_list: D004121:Dimethyl Sulfoxide